Federal contract award
75N98121F00001
GDIT PROGRAM SUPPORT 2020 HHS ACF OCSE BASE PERIOD AWARD POP 11/09/2020-05/08/2021. TOTAL BASE PERIOD AWARD VALUE $7,892,731.56. TOTAL TASK ORDER LIFECYLE $77,649,911.76.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NIH NITAA DITA-DVI OF INFO TECH ACQ |
| NAICS | 541512 — Computer Systems Design Services |
| PSC | DA01 — Support services for activities involved with application development and support to include analysis, design, development, coding, testing, and release packaging, as well as support of off-the-shelf Business Applications. |
| Parent award / vehicle | HHSN316201200023W |
| Set-aside | Not reported |
| Pricing type | TIME AND MATERIALS |
| Obligations | $81.1M |
| Current contract value | $81.1M |
| Potential contract value / ceiling | $89.1M |
| Start date | Nov 9, 2020 |
| Current end date | May 8, 2026 |
| Potential end date | May 8, 2026 |
| Latest award activity | May 6, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 27 of 27 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 6, 2026 | P00026 | $-846.2K | DEOBLIGATE FUNDING |
| Sep 30, 2025 | P00025 | $6.8M | EXERCISE 52.217-8 |
| May 8, 2025 | P00024 | $6.8M | THE PURPOSE OF MODIFICATION P00023 IS TO ADMINISTRATIVELY UPDATE KEY PERSONNEL POSITIONS ON THE CONTRACT FOR MS. CHRISTA AROCHA-DE LEON TO BE RECOGNIZED AS THE NEW EMP LOB LEAD AND MS. JESSICA RAMSEY TO REPLACE THE ROLE OF CLI EMP LOB AFTER MS. MUCCI |
| Mar 20, 2025 | P00023 | $0 | THE PURPOSE OF MODIFICATION P00023 IS TO ADMINISTRATIVELY UPDATE KEY PERSONNEL POSITIONS ON THE CONTRACT FOR MS. CHRISTA AROCHA-DE LEON TO BE RECOGNIZED AS THE NEW EMP LOB LEAD AND MS. JESSICA RAMSEY TO REPLACE THE ROLE OF CLI EMP LOB AFTER MS. MUCCI |
| Jan 13, 2025 | P00022 | $0 | THE PURPOSE OF MODIFICATION P00022 IS TO ADMINISTRATIVELY UPDATE CLIN TITLE DESCRIPTIONS FOR CLINS 8006 AND 9006 THAT WERE COMPLETED FOR THE BASE PERIOD CLIN 0006 BUT WERE NOT ROLLED FORWARD IN THE OUTYEAR CLIN TITLE UPDATES. MODIFICATION P00022 PRO |
| Dec 6, 2024 | P00021 | $0 | THE PURPOSE OF MODIFICATION P00021 IS TO ADD 52.204-30 AS FOLLOWS: 52.204-30, FEDERAL ACQUISITION SUPPLY CHAIN SECURITY ACT ORDERS-PROHIBITION. (DEC 2023) IS INCLUDED WITH ITS ALTERNATE II AS FOLLOWS: 52.204-30 FEDERAL ACQUISITION SUPPLY CHAIN |
| Sep 3, 2024 | P00020 | $7.9M | MODIFICATION P00020 EXERCISES AND FULLY FUNDS OPTION PERIOD 8 IN THE AMOUNT OF $7,923,686.64 AND A PERIOD OF PERFORMANCE OF 11/09/2024-05/08/2025. THE TOTAL CONTRACT OBLIGATION AMOUNT IS HEREBY CHANGED FROM: $60,459,316.83 TO: $68,383,003.47 AN IN |
| Jul 31, 2024 | P00019 | $0 | THE PURPOSE OF THIS NO-COST, BILATERAL MODIFICATION P00019: INCORPORATE PWS DATED 07/29/2024 THE TOTAL OBLIGATED CONTRACT AMOUNT REMAINS UNCHANGED. THE TOTAL LIFECYCLE CONTRACT VALUE REMAINS UNCHANGED. ALL OTHER TERMS AND CONDITIONS REMA |
| Jul 16, 2024 | P00018 | $-1.3M | THE PURPOSE OF MODIFICATION P00018: DEOBLIGATE $1,604,189.79 EXCESS "NO-YEAR" FUNDS FROM TASK ORDER CLINS IN WHICH PERFORMANCE IS COMPLETED. SEE SCHEDULE FOR CLIN AND AMOUNTS. ADD NEW CLIN 7008 (TASK 4)- NATIONAL PUTATIVE FATHER REGIS |
| Apr 26, 2024 | P00017 | $7.7M | THE PURPOSE OF MODIFICATION P00017 IS TO EXERCISE AND FULLY FUND $7,725,934.50 FOR OPTION PERIOD 7 CLINS 7001-7007. THE PERIOD OF PERFORMANCE IS 05/09/2024 - 11/08/2024. MODIFICATION P00017 CHANGES THE TOTAL OBLIGATION FROM $54,051,548.12 TO $61,777 |
| Sep 11, 2023 | P00016 | $0 | THE PURPOSE OF THIS ADMINISTRATIVE MODIFICATION P00016 IS TO CORRECT THE PERIOD OF PERFORMANCE IN BLOCK 14 OF MODIFICATION P00015. FROM: 11/09/2023 - 05/09/2024 TO: 11/09/2023 - 05/08/2024. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED. |
| Sep 5, 2023 | P00015 | $7.7M | THE PURPOSE OF MODIFICATION P00015 IS TO EXERCISE AND FULLY FUND $7,724,944.90 FOR OPTION PERIOD 6 CLINS 6001-6007. THE PERIOD OF PERFORMANCE IS 11/09/2023 - 05/08/2024. MODIFICATION P00015 CHANGES THE TOTAL OBLIGATION FROM $46,326,603.22 TO $54,051 |
| May 7, 2023 | P00014 | $7.5M | THE PURPOSE OF MODIFICATION P00014 IS TO EXERCISE AND FULLY FUND $7,532,823.66 FOR OPTION PERIOD 5 CLINS 5001-5007. THE PERIOD OF PERFORMANCE IS 05/09/2023 - 11/08/2023. MODIFICATION P00014 CHANGES THE TOTAL OBLIGATION FROM $38,793,779.56 TO $46,326 |
| Dec 5, 2022 | P00013 | $57.2K | THE PURPOSE OF SUPPLEMENTAL AGREEMENT MODIFICATION P00013 IS TO PERFORM THE FOLLOWING CONTRACT ACTIONS AS DESCRIBED BY THE ACCEPTED GDIT DECEMBER 2, 2022 PROPOSAL THAT IS INCORPORATED IN THIS CONTRACT ACTION. AS A RESULT OF THIS MODIFICATION, THE TO |
| Oct 19, 2022 | P00012 | $7.6M | THE PURPOSE OF MODIFICATION P00012 IS TO EXERCISE AND FULLY FUND $7,636,628.46 FOR OPTION PERIOD 4 CLINS 4001-4006. THE PERIOD OF PERFORMANCE IS 11/09/2022 - 05/08/2023. MODIFICATION P00012 CHANGES THE TOTAL OBLIGATION FROM $31,099,959.90 TO $38,736 |
| Sep 28, 2022 | P00011 | $0 | THE PURPOSE OF UNILATERAL ADMIN MOD 00011 IS TO UPDATE THE UEI SAM CODE FOR THIS TASK ORDER FROM XBS3MLJD5KK3 TO SMNWM6HN79X5. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED. |
| Apr 20, 2022 | P00010 | $7.5M | THE PURPOSE OF MODIFICATION P00010 IS TO EXERCISE AND FULLY FUND $7,539,612.58 FOR OPTION PERIOD 3 CLINS 3001-3006. THE PERIOD OF PERFORMANCE IS 05/09/2022 - 11/08/2022. MODIFICATION P00010 CHANGES THE TOTAL OBLIGATION FROM $23,560,347.32 TO $31,099 |
| Mar 1, 2022 | P00009 | $0 | DUE TO FY22 OCSE BUDGET CONSTRAINTS, THIS TASK ORDER MUST UNDERGO A 10% BUDGET REDUCTION STARTING OPTION 3 MAY 2022 THROUGH OPTION 9 NOVEMBER 2025. THE PURPOSE OF MODIFICATION P00009 IS TO PERFORM THE FOLLOWING CONTRACT ACTIONS IN RESPONSE TO T |
| Jan 11, 2022 | P00008 | $0 | THE PURPOSE OF BI-LATERAL MODIFICATION P00008 IS TO RE-DESCRIBE CLIN 2006 FROM "TRAVEL" TO "TRAVEL AND SOFTWARE LICENSES". ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED. |
| Sep 9, 2021 | P00007 | $7.9M | MODIFICATION P00007 EXERCISE OPTION PERIOD 2 - CLINS 2001-2006. $7,900,547.72.PERIOD OF PERFORMANCE 11/09/2021-05/08/2022. |
| Jul 26, 2021 | P00006 | $0 | THE PURPOSE OF THIS NO COST BI-LATERAL MODIFICATION P00006 IS TO PERFORM SUPPLEMENTAL CHANGES TO THE OCSE PWS, SECTION 3.1.3.4 OCSE LEGISLATIVE, INTERNATIONAL AND DATA ANALYSIS SUPPORT. OCSE PWS P00006 7.26.21 SUPERSEDES THE PRIOR PWS P00004 3.10.21 |
| May 5, 2021 | P00005 | $7.8M | THE PURPOSE OF MODIFICATION P0005 IS TO PERFORM THE FOLLOWING ACTIONS: --FULLY FUND AND EXERCISE ALL OPTION PERIOD 1 CLINS. TOTAL FUNDING FOR P0005 IS $7,767,068.04. --RE-DESCRIBE CLIN 1003 AND REDUCE FUNDING AMOUNT. RE-DESCRIBED AS CLIN 1003 OPTIO |
| Mar 9, 2021 | P00004 | $0 | THE PURPOSE OF THIS BI-LATERAL MODIFICATION P00004 IS TO PERFORM THE FOLLOWING SUPPLEMENTAL CHANGES TO TASK 1 OF THE TASK ORDER AND OCSE PWS P00004 3.10.21 SUPERSEDES THE PRIOR PWS OCSE PWS P00003 3.10.21. AS A RESULT OF THE PWS CHANGES, THE TASK OR |
| Feb 10, 2021 | P00003 | $0 | THE PURPOSE OF THIS BI-LATERAL NO-COST MODIFICATION P00003 IS FOR A SUPPLEMENTAL CHANGE TO THE TASK ORDER TO CHANGE THE AWARD TYPE FROM FIRM FIXED PRICE (FFP) TO COST REIMBURSEMENT (CR) FOR FOLLOWING BASE AND OPTION PERIOD CLINS: -- ODC (MATERIALS |
| Feb 1, 2021 | P00002 | $0 | THE PURPOSE OF UNILATERAL ADMINISTRATIVE MODIFICATION P00002 IS TO CHANGE THE PAYMENT OFFICE FROM DITA-NITAAC TO ASSISTED-NITAAC. ALL TERMS AND CONDITIONS OF THE TASK ORDER REMAIN UNCHANGED. |
| Jan 4, 2021 | P00001 | $0 | THE PURPOSE OF ADMINISTRATIVE MODIFICATION P00001 IS TO UPDATE THE PWS WITH THE CORRECT COR. P00001 REMOVED COR LINDA BOYER AND REPLACED WITH THE CORRECT COR, SHERRI GRIGSBY. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED. |
| Nov 4, 2020 | 0 | $7.9M | GDIT PROGRAM SUPPORT 2020 HHS ACF OCSE BASE PERIOD AWARD POP 11/09/2020-05/08/2021. TOTAL BASE PERIOD AWARD VALUE $7,892,731.56. TOTAL TASK ORDER LIFECYLE $77,649,911.76. |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.